BRCA1 and breast carcinoma: While the penetrance varies by family history and specific gene variants, women with a pathogenic variant (PV) in the BRCA1 or the BRCA2 gene (BRCA1/2 carriers) have an estimated cumulative lifetime risk of developing breast cancer of 50–72% [1–4].